Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 12-2018 | |
Sales | 9,362 | 11,228 | 4,657 | 0 | 0 |
Gross Profit | 9,362 | 11,228 | 4,657 | N/A | N/A |
Operating Expenses | 11,130 | 12,082 | 6,779 | 0 | 0 |
Operating Income | -1,768 | -854 | -2,122 | N/A | N/A |
Other Income | -925 | 7,557 | 29 | 0 | 0 |
Pre-tax Income | -2,693 | 6,703 | -2,093 | 0 | 0 |
Net Income Continuous | -2,693 | 6,703 | -2,093 | N/A | N/A |
Net Income | $-2,693 | $6,703 | $-2,093 | $N/A | $N/A |
EPS Basic Total Ops | -0.02 | 0.03 | -0.01 | N/A | N/A |
EPS Basic Continuous Ops | -0.02 | 0.04 | -0.01 | N/A | N/A |
EPS Diluted Total Ops | -0.02 | 0.03 | -0.01 | N/A | N/A |
EPS Diluted Continuous Ops | -0.02 | 0.03 | -0.01 | N/A | N/A |
EBITDA(a) | $-831 | $226 | $-1,476 | $N/A | $N/A |